The role of PPARγ in hepatocellular carcinoma

PPAR Research

Volumn , Issue , 2008, Pages

  Borbath, Ivan ^a   Horsmans, Yves ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; TROGLITAZONE;

ANTINEOPLASTIC ACTIVITY; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE COURSE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; IMMUNOMODULATION; LIVER CELL CARCINOMA; LIVER FIBROSIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

EID: 45249084803     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/209520     Document Type: Review

References (33)

1. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002 CA: Cancer Journal for Clinicians 2005 55 2 74 108
2. Chang M.-H., Chen C.-J., Lai M.-S., Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children The New England Journal of Medicine 1997 336 26 1855 1859
3. Mazzaferro V.
4. Michalik L., Desvergne B., Wahli W.
5. Saez E., Tontonoz P., Nelson M. C., Activators of the nuclear receptor PPAR γenhance colon polyp formation Nature Medicine 1998 4 9 1058 1061
6. Rumi M. A. K., Sato H., Ishihara S., Peroxisome proliferator-activated receptor γligand-induced growth inhibition of human hepatocellular carcinoma British Journal of Cancer 2001 84 12 1640 1647
7. Koga H.
8. Okano H., Shiraki K., Inoue H., Peroxisome proliferator-activated receptor γaugments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma Anti-Cancer Drugs 2002 13 1 59 65
9. Toyoda M., Takagi H., Horiguchi N., A ligand for peroxisome proliferator activated receptor γinhibits cell growth and induces apoptosis in human liver cancer cells Gut 2002 50 4 563 567
10. Shen Y.-C., Hsu C.
11. Motomura W., Takahashi N., Nagamine M., Growth arrest by troglitazone is mediated by p27 Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells International Journal of Cancer 2004 108 1 41 46
12. Koga H., Sakisaka S., Harada M., Involvement of p21 WAF1/Cip1, p27 Kip1, and p18 INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell lines Hepatology 2001 33 5 1087 1097
13. Schaefer K. L.
14. Yu J., Qiao L., Zimmermann L., Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo Hepatology 2006 43 1 134 143
15. Vidal-Puig A. J.
16. Cheng J.
17. Okano H., Shiraki K.
18. Yoshizawa K.
19. Kawaguchi K., Sakaida I.
20. Pitot H. C., Altered heptic foci: their role in murine hepatocarcinogenesis Annual Review of Pharmacology and Toxicology 1990 30 465 500
21. Guo Y. T.
22. Borbath I.
23. Palakurthi S. S., Aktas H., Grubissich L. M., Mortensen R. M., Halperin J. A., Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γand mediated by inhibition of translation initiation Cancer Research 2001 61 16 6213 6218
24. Galli A., Crabb D. W., Ceni E., Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro Gastroenterology 2002 122 7 1924 1940
25. Hazra S., Xiong S., Wang J., Peroxisome proliferator-activated receptor γinduces a phenotypic switch from activated to quiescent hepatic stellate cells Journal of Biological Chemistry 2004 279 12 11392 11401
26. Planagumà A., Clària J.
27. Da Silva Morais A., Abarca-Quinones J., Horsmans Y., Stärkel P., Leclercq I. A., Peroxisome proliferated-activated receptor γligand, Pioglitazone, does not prevent hepatic fibrosis in mice International Journal of Molecular Medicine 2007 19 1 105 112
28. Leclercq I. A.
29. Belfort R., Harrison S. A., Brown K., A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis The New England Journal of Medicine 2006 355 22 2297 2307
30. Yamamoto Y., Nakajima M., Yamazaki H., Yokoi T.
31. Li M.-Y.
32. Li M.-Y.
33. Kim K. R., Choi H. N., Lee H. J., A peroxisome proliferator-activated receptor γantagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma Oncology Reports 2007 18 4 825 832